BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 34, 2008, Pages 12435-12438

  Otipoby, Kevin L ^a   Sasaki, Yoshiteru ^a,e   Schmidt Supprian, Marc ^a,f   Patke, Alina ^b   Gareus, Ralph ^c,d   Pasparakis, Manolis ^c,d   Tarakhovsky, Alexander ^b   Rajewsky, Klaus ^a,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^e RIKEN Center for Biosystems Dynamics Research   (Japan)

^f MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^g CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; I KAPPA B KINASE; I KAPPA B KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL SIZE; CELLS, CULTURED; HOMEOSTASIS; I-KAPPA B KINASE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 50449086797     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805460105     Document Type: Article

References (31)

1. Schiemann B, et al. (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-2114.
2. Gross JA, et al. (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 15:289-302.
3. Bossen C, Schneider P (2006) BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 18:263-275.
4. Yan M, et al. (2001) Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2:638-643.
5. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M (2004) TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173:2245-2252.
6. Shulga-Morskaya S, et al. (2004) B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 173:2331-2341.
7. von Bulow GU, van Deursen JM, Bram RJ (2001) Regulation of the T-independent humoral response by TACI. Immunity 14:573-582.
8. Xu S, Lam KP (2001) B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 21:4067-4074.
9. Claudio E, Brown K, Park S, Wang H, Siebenlist U (2002) BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3:958-965.
10. Kayagaki N, et al. (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17:515-524.
11. Enzler T, et al. (2006) Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25:403-415.
12. Gerondakis S, Strasser A (2003) The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin Immunol 15:159-166.
13. Siebenlist U, Brown K, Claudio E (2005) Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5:435-445.
14. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A (2006) BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203:2551-2562.
15. Craxton A, Draves KE, Gruppi A, Clark EA (2005) BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 202:1363-1374.
16. Woodland RT, et al. (2008) Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111:750-760.
17. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8:49-62.
18. Dan HC, Adli M, Baldwin AS (2007) Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha. Cancer Res 67:6263-6269.
19. Thompson JS, et al. (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108-2111.
20. Yan M, et al. (2001) Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 11:1547-1552.
21. Woodland RT, Schmidt MR, Thompson CB (2006) BLyS and B cell homeostasis. Semin Immunol 18:318-326.
22. Kaisho T, et al. (2001) I kappa B kinase alpha is essential for mature B cell development and function. J Exp Med 193:417-426.
23. Senftleben U, et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
24. Hatada EN, et al. (2003) NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol 171:761-768.
25. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA (2004) Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104:784-787.
26. Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP (2002) Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol 168:5993-5996.
27. Do RK, et al. (2000) Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 192:953-964.
28. Sasaki Y, et al. (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24:729-739.
29. Gareus R, et al. (2007) Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 9:461-469.
30. Hobeika E, et al. (2006) Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci USA 103:13789-13794.
31. Strasser A, et al. (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661-8665.